Description
Sulcarb 800mg Tablet | Sevelamer Carbonate Phosphate Binder for CKD & Dialysis | Pharma Services Group
Selcarb 800mg Tablet contains Sevelamer Carbonate 800mg, a non-absorbed phosphate binder used to help control elevated serum phosphorus levels in patients with chronic kidney disease (CKD) who are on dialysis. Sevelamer carbonate binds dietary phosphate in the gastrointestinal tract, reducing its absorption and helping manage serum phosphorus levels.
Selcarb is supplied as an oral tablet and is generally taken with meals according to the dosage prescribed by the treating physician. Appropriate dosing depends on the patient’s serum phosphorus level and clinical condition.
Key Benefits
- Contains Sevelamer Carbonate 800mg
- Helps control elevated serum phosphorus
- Used in patients with chronic kidney disease on dialysis
- Binds dietary phosphate in the gastrointestinal tract
- Non-absorbed phosphate-binding formulation
- Oral tablet formulation for convenient administration
How It Works
Sevelamer Carbonate is a non-absorbed phosphate-binding polymer. In the gastrointestinal tract, it binds phosphate through ionic and hydrogen bonding, reducing phosphate absorption and helping lower serum phosphorus levels.
Indications
Selcarb 800mg is indicated for the control of serum phosphorus in adults and children aged 6 years and older with chronic kidney disease on dialysis, as directed by a healthcare professional.
Directions for Use
Take Selcarb exactly as prescribed by your physician. Sevelamer carbonate tablets are generally taken with meals. Do not change the dose or stop treatment without medical advice.
Because Sevelamer Carbonate can affect the absorption of certain oral medicines, some medicines may need to be taken at a different time. Follow your physician’s or pharmacist’s instructions regarding medication timing.
Precautions
- Use only under medical supervision.
- Inform your doctor about all medicines and supplements you are taking.
- Tell your doctor if you have difficulty swallowing or gastrointestinal problems.
- Report new or worsening constipation or bloody stools promptly.
- Maintain the prescribed diet and dialysis schedule.
- Keep out of reach of children.
Possible Side Effects
Possible adverse effects may include constipation, nausea, vomiting, abdominal discomfort, diarrhea, indigestion, and other gastrointestinal symptoms. Seek medical attention for severe or persistent symptoms.
Active Ingredient
Sevelamer Carbonate — 800mg per tablet
Dosage Form
Film-coated tablet
Prescription Status
Prescription medicine — use only as directed by a qualified healthcare professional.
Pack Size
3 × 10’s — 30 tablets
Manufacturer
Genome Pharma
Product information provided identifies Genome Pharma as the manufacturer.
Storage Instructions
Store according to the instructions provided on the product packaging. Protect the tablets from moisture and keep them in a dry place at the recommended temperature.
Product Specifications
| Specification | Details |
|---|---|
| Product Name | Selcarb 800mg Tablet |
| Generic Name | Sevelamer Carbonate |
| Strength | 800mg |
| Dosage Form | Film-coated Tablet |
| Drug Class | Phosphate Binder |
| Therapeutic Use | Control of serum phosphorus |
| Primary Indication | CKD patients on dialysis |
| Route | Oral |
| Pack Size | 3 × 10’s |
| Manufacturer | Genome Pharma |
| Prescription Status | Prescription Medicine |
Brand
Brand
IPRAM PHARMACEUTICALS INTL

Reviews
There are no reviews yet.